Search

  • HOME
  • Search
Original Articles
2131
Effects of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination on the Atherosclerosis-Related Process in a Type 2 Diabetes Mouse Model
Jin Hee Kim, Gha Young Lee, Hyo Jin Maeng et al.
Endocrinol Metab. 2021;36(1):157-170.   Published online February 24, 2021
Full textFull text    PubreaderPubReader    ePubePub    CrossRef-TDMCrossref - TDM    PDFPDF    PDFSupplementary Material
Association between Serum Fibroblast Growth Factor 21 Levels and Bone Mineral Density in Postmenopausal Women
Hoon Sung Choi, Hyang Ah Lee, Sang-Wook Kim, Eun-Hee Cho
Endocrinol Metab. 2018;33(2):273-277.   Published online June 21, 2018
Full textFull text    PubreaderPubReader    CrossRef-TDMCrossref - TDM    PDFPDF    
Review Articles
Fibroblast Growth Factor 21 Mimetics for Treating Atherosclerosis
Kelvin H. M. Kwok, Karen S. L. Lam
Endocrinol Metab. 2017;32(2):145-151.   Published online May 19, 2017
Full textFull text    PubreaderPubReader    CrossRef-TDMCrossref - TDM    PDFPDF    
Novel Molecules Regulating Energy Homeostasis: Physiology and Regulation by Macronutrient Intake and Weight Loss
Anna Gavrieli, Christos S. Mantzoros
Endocrinol Metab. 2016;31(3):361-372.   Published online July 26, 2016
Full textFull text    PubreaderPubReader    CrossRef-TDMCrossref - TDM    PDFPDF    
Transcriptional Regulation of Fibroblast Growth Factor 21 Expression
Kwi-Hyun Bae, Jung-Guk Kim, Keun-Gyu Park
Endocrinol Metab. 2014;29(2):105-111.   Published online June 26, 2014
Full textFull text    PubreaderPubReader    CrossRef-TDMCrossref - TDM    PDFPDF    

Endocrinology
and Metabolism

Print ISSN: 2093-596X
Online ISSN: 2093-5978



Editorial Office
101-2503, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea​
Tel: +82-2-716-2428    Fax: +82-2-714-5103    E-mail: journal@endocrinology.or.kr                

Copyright © 2021 by Korean Endocrine Society. All rights reserved.

Developed in M2PI

Close layer
prev next